---
title: 臨床試驗 Clinical Trials
author: Jeff Lin
date: '2020-08-20'
slug: []
categories:
  - clinical trial
  - biostatistics
  - R 
tags:
  - clinical trial
  - biostatistics
  - R 
event: null
event_url: null
location: null
address:
  street: null
  city: null
  region: null
  postcode: null
  country: null
summary: null
abstract: null
date_end: '2020-08-20T15:49:52+08:00'
all_day: no
publishDate: '2020-08-20T15:49:52+08:00'
authors: []
featured: no
image:
  caption: ''
  focal_point: ''
  preview_only: no
url_slides: null
url_code: null
url_pdf: null
url_video: null
slides: ''
projects: []
output: 
  html_document: 
    fig_width: 4
    fig_height: 3
    keep_md: yes
    number_sections: true

---

<script src="/rmarkdown-libs/header-attrs/header-attrs.js"></script>


<p>臨床試驗課程主要討論討二大主題:
a) 臨床試驗設計與分析, 著重在統計相關議題.
b) 基礎醫學與臨床醫學共通的實驗設計與分析,
著重在一般生物醫學的實驗設計與資料分析.</p>
<div id="臨床試驗設計與分析" class="section level3">
<h3>臨床試驗設計與分析</h3>
<ul>
<li><p>Introduction and Protocol</p></li>
<li><p>Ethics</p></li>
<li><p>Study Population and Outcome Measures</p></li>
<li><p>Study Controls</p></li>
<li><p>Basic Design</p></li>
<li><p>Randomization</p></li>
<li><p>Blinding</p></li>
<li><p>Sample Size</p></li>
<li><p>Safety Assessment</p></li>
<li><p>Quality of Life</p></li>
<li><p>Recruitment and Retaining of Participants</p></li>
<li><p>Data Safety Monitoring Committee</p></li>
<li><p>Interim Analysis</p></li>
<li><p>Data Analysis</p>
<ul>
<li>Baseline Assessment<br />
</li>
<li>Analysis Set: ITT and PP</li>
<li>Ineligibility</li>
<li>Nonadherence</li>
<li>Poor Quality Data</li>
<li>Competing Events</li>
<li>Missing Data</li>
<li>Multiple Comparisons</li>
<li>Adjustment of Covariates</li>
<li>Subgroup Analysis</li>
</ul></li>
<li><p>Reporting and Interpreting of Results</p></li>
<li><p>Equivalence and Noninferiority</p></li>
<li><p>Phase I Design</p></li>
<li><p>Phase II Design</p></li>
<li><p>Dose-Finding Design</p></li>
<li><p>Cancer Clinical Trial</p></li>
<li><p>Diagnostic Devices</p></li>
<li><p>Biomarker and Translation Medicine</p></li>
<li><p>Precision Medicine and Targeted Therapy</p></li>
<li><p>Vaccine Trial</p></li>
<li><p>Adaptive Design</p></li>
<li><p>Regulatory issues: ICH E9 and ICH E9 (R1)</p></li>
</ul>
</div>
<div id="醫學實驗設計與分析" class="section level3">
<h3>醫學實驗設計與分析</h3>
<ul>
<li>Basic Concepts in Experiments
<ul>
<li>Experimental Unit and Replications</li>
<li>Randomization</li>
<li>Treatment Design and Experimental Design</li>
<li>Crossed or Nested</li>
<li>Complete or INcomplete</li>
<li>Replications: True or Technical</li>
<li>Data layout or Field</li>
<li>Fixed Factors and Random Factors</li>
</ul></li>
<li>CRD (Completely Randomized Designs)
<ul>
<li>One Way ANOVA</li>
<li>Multiple Testings and Multiple Comparisons</li>
<li>Fixed and Random Factors/Effects</li>
</ul></li>
<li>CRD
<ul>
<li>Two Fixed Factors</li>
<li>Balanced and Unbalanced</li>
<li>Interaction</li>
<li>ANCOVA (Analysis of Covariances)</li>
</ul></li>
<li>RCBD/CBD (Randomized Complete Block Designs)
<ul>
<li>Block: Fixed or Random?</li>
<li>RCBD Variations</li>
<li>Replications</li>
<li>Crossed Blocks</li>
<li>LSD (Latin/Eular Square Design)</li>
<li>GLSD (Graceo+Latin Square Design)</li>
</ul></li>
<li>SPD (Split Plot Design)
<ul>
<li>CRD on the Whole Plots</li>
<li>RCBD on the Whole Plots</li>
<li>SSPD (Split Split Plot Design)</li>
<li>SBD (Strip Plot Designs, Split Block Design)</li>
<li>Crossover Design</li>
<li>RMD (Repeated Measures Design)</li>
</ul></li>
<li>FD (Factorial Design)</li>
<li>Incomplete Design
<ul>
<li>BIBD (Balanced Incompete Block Design)</li>
<li>FFD (Fractional Factorial Design)</li>
</ul></li>
</ul>
</div>
